Taisho Pharmaceutical Co., Ltd.

Japon


 
Quantité totale PI 861
Quantité totale incluant filiales 867 (+ 7 pour les filiales)
Rang # Quantité totale PI 1 513
Note d'activité PI 3,2/5.0    326
Rang # Activité PI 2 186
Parent Otsuka Holdings Co., Ltd.
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

198 83
86 2
465 17
10
 
Dernier brevet 2025 - Treatment methods for subjects w...
Premier brevet 1976 - Method for preparing 17 .alpha.-...
Dernière marque 2024 - JESELHY
Première marque 1982 - LIPOVITAN

Filiales

1 subsidiaries with IP (1 patents, 6 trademarks)

2 subsidiaries without IP

 S'inscrire grtuitement pour accéder à la liste des filiales

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 P/S Pharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treat...
P/S Pharmaceutical preparations; medicinal drinks; tonics (medicines); vitamin preparations; nutritio...
Invention Treatment methods for subjects with non-small cell lung cancer having an aberration in egfr. A me...
Invention Crystal of quinoline-substituted compound. The present invention addresses the problem of providi...
Invention Pharmaceutical composition. The purpose of the present invention is to provide a pharmaceutical c...
Invention Prophylactic drug/therapeutic drug for progressive supranuclear palsy. Provided is a novel prophy...
Invention Antibody-drug conjugate containing anti-cd138 antibody. Provided is an antibody-drug conjugate (A...
Invention Ftd-tpi combination preparation, pd-1 pathway antagonist, and combination use of vegf pathway ant...
Invention Combination therapy using azabicyclo compound for cancer. Provided is a novel method for treatin...
Invention Method for treating cancer patients with severe renal impairment. A method for treating cancer i...
2023 Invention Crystals of acetate hydrochloride. The present invention provides I form crystals of 4-piperidiny...
Invention Selective inhibitor of exon 20 insertion mutant egfr. An antitumor agent comprising a compound s...
Invention 5h-pyrrolo[2,3-d]pyrimidin-6(7h)-one and crystal of salt thereof. Provided is a type-I crystal of...
Invention Analogues of azabicyclic compounds. Provided are novel compounds which are analogues to be remove...
Invention Pharmaceutical composition containing pimitespib. Provided is a pharmaceutical composition contai...
Invention Combination decitabine and cedazuridine solid oral dosage forms. 2 administered as a one hour (1 ...
P/S Advertising and publicity services; business management analysis and business consultancy; busine...
Invention Crystal of 7h-pyrrolo[2,3-d]pyrimidine-4-amine derivative. Provided is a crystal of a compound ha...
Invention Method for producing 7h-pyrrolo[2,3-d]pyrimidine-4-amine derivative. 11 in formula (II) under bas...
Invention Prophylactic or therapeutic agent, for lung inflammation and fibrosis, containing compound having...
Invention Ph-dependent anti-sulfated glycosaminoglycan antibody and antibody-drug conjugate. Provided is an...
Invention Stabilized formulation for fosnetupitant or pharmaceutically acceptable salt thereof, and a metho...
Invention Crystal form of cyclohexenone compound. The purpose of the present disclosure is to provide a cry...
2022 Invention Small molecule inhibitors of kras mutated proteins. Compounds of Formula (I) or their pharmaceuti...
Invention Process for preparing a benzoate salt of a 1-(3-aminopyrrolidine-1-carbonyl)-3,4-diphenylbenzene ...
Invention Treatment methods for subjects having cancer with a dysregulated mapk and/or pi3k pathway. A met...
Invention Treatment methods for subjects having cancer with a dysregulated mapk and/or pi3k pathway. A meth...
Invention Anti-growth hormone antibody. In one embodiment, the present invention provides an antibody spec...
Invention New juniper pollen protein. The present disclosure relates to a juniper pollen protein selected f...
Invention Small molecule inhibitors of kras mutated proteins. Compounds of Formula (I) or their pharmaceut...
Invention Treatment methods for subjects with cancer having an aberration in egfr and/or her2. A method of...
Invention Solid forms of salts of 4-[5-[(3s)-3-aminopyrrolidine-1-carbonyl]-2-[2-fluoro-4-(2- hydroxy-2-eth...
Invention Treating cancer in patient with pten inactivating mutation. A method of treating a subject with ...
2021 Invention Brain-migrating tumor therapeutic agent containing fused pyrimidine compound as active ingredient...
Invention Crystalline forms of 4-amino-n-[4-(methoxymethyl)phenyl]-7-(1-methylcyclopropyl)-6-(3-morpholinop...
Invention Methods of using 4-amino-n-[4-(methoxymethyl)phenyl]-7-(1-methylcyclopropyl)-6-(3-morpholinoprop-...
Invention Methods of treating ribonucleotide reductase-related diseases with a ribonucleotide reductase inh...
Invention Treatment regimens for exon-20 insertion mutant egfr cancers. Treatment regimens for exon 20 ins...
Invention Treating cancer in patient having co-occurring genetic alteration in fgfr2 and a cancer driver ge...
Invention Novel cycloalkenone compound or salt thereof. Provided are a compound represented by formula (I)...
Invention Crystal of pyrimidine compound. A crystal of 7-((3R,5S)-1-acryloyl-5-methylpyrrolidin-3-yl)-4-am...
Invention Egfr inhibitor. Provided is a therapeutic agent for a disease associated with EGFR, the agent co...
Invention Pyrimidine compound-containing combination to be used in tumor treatment. Provided is a tumor tr...
Invention Urinary symptom therapeutic agent. The present invention addresses the problem of providing a vo...
P/S Application software; computer programs; electronic machines, apparatus and their parts; smartph...
P/S Downloadable application software for processing images, graphics and text; downloadable computer...
P/S Pharmaceutical, veterinary and sanitary preparations; dietary supplements for medical purposes; D...
Invention Anticancer combination therapy with n-(1-acryloyl-azetidin-3-yl)-2-((1h-indazol-3-yl)amino)methyl...
Invention Kras g12d protein inhibitors. Compounds and pharmaceutically acceptable salts thereof inhibit th...
P/S Anti-cancer preparations; pharmaceutical preparations for the treatment of tumors; chemical reage...
Invention Cancer therapy using 3,5-disubstituted benzene alkynyl compound and mek inhibitor. Provided is a...
P/S Anti-cancer preparations; pharmaceutical preparations for the treatment of tumor; chemical reagen...
P/S Anti-cancer preparations; pharmaceutical preparations for the treatment of tumors
P/S Breath freshening strips; breath freshening sprays; breath freshening preparations for personal h...
P/S Non-medicated hand soaps, body wash and laundry detergents; cosmetics; body sprays used as person...
Invention Process for producing acylthiourea compound. The present invention relates to a process for prod...
Invention Enhancement of anti-tumor activity of shp2 inhibitor pyrimidinone in combination with novel cance...
2020 P/S Meteorological information; architectural design; surveying; geological research; geological surv...
P/S Pharmaceutical preparations for the treatment of tumors; pharmaceutical preparations for the trea...
Invention A compound having inhibitory activity against kras g12d mutation. The present invention relates ...
Invention Polypeptide having mmp2-inhibitory effect. The present invention provides a substituted polypept...
P/S Pharmaceutical preparations; Preparations for use in the prevention and treatment of motion sickn...
P/S Pharmaceutical preparations for treating cancer; pharmaceutical preparations for treating immune ...
2019 P/S Pharmaceutical preparations for the treatment of osteoarthritis; pharmaceutical preparations for ...
P/S Dentifrices; cosmetics; toilet waters; beauty serums; cosmetics, namely, foundation makeup; make-...
P/S Dentifrices; cosmetics; toilet waters; beauty serums; cosmetics, namely, base makeup; make-up po...
P/S Laundry and bleaching preparations, namely, laundry detergent and laundry bleach; breath fresheni...
P/S Business consultancy relating to business management, sales, acquisitions and mergers; business r...
P/S Pharmaceutical preparations for human use, namely, for the treatment of diabetes